Outpatient parenteral antimicrobial therapy (OPAT) offers benefits for patients as well as providing cost effectiveness; however, it is not without its challenges. Two clinicians provide insights on this modality.
Dana Holger, PharmD, MPH, AAHIVP
Advertisement
Dana Holger, PharmD, MPH, AAHIVP, practices as an assistant professor in the Department of Pharmacy Practice at Nova Southeastern University in Fort Lauderdale, Florida.
Articles by Dana Holger, PharmD, MPH, AAHIVP
Advertisement
Latest Updated Articles
Tricky Infusion Issues and Potential Solutions: OPAT EditionPublished: May 4th 2023 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Understanding the Importance of Bird Migration as it Relates to Avian Influenza
2
Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists
3
25-Year US Analysis Links Most Fatal C difficile Cases to White Patients, Women, and Urban Care Settings
4
